Quality by Design for Generic Drugs - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Quality by Design for Generic Drugs
The authors relay the outcome of a two-day workshop that brought together regulators and generic-drug industry representatives.

Pharmaceutical Technology
Volume 33, Issue 10, pp. 122-127


1. ICH, ICH Q8(R1) Pharmaceutical Development/Annex (Geneva, November 2008).

2. L. X. Yu. "Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control," Pharm. Res. 25 (4), 781–791 (2008).

3. R. Lionberger et al., "Quality by Design: Concepts for ANDAs," The AAPS Journal. 10 (2), 268–276 (2008).

4. L. S. Lee, A. Raw, and L. X. Yu, "Dissolution Testing," in Biopharmaceutics Applications in Drug Development, R. Krishna and Lawrence X. Yu, Eds. (Springer, New York, NY, 2008), pp. 47–74.

5. ICH, ICH Q9 Quality Risk Management (Geneva, November 2005).

6. ICH Quality Implementation Working Group, Q8, Q9, and Q10 Questions and Answers, http://www.ich.org/LOB/media/MEDIA5290.pdf, accessed Aug. 26, 2009.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: Pharmaceutical Technology,
Click here